Voyager Therapeutics, Inc. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 836.77%-171.18%-282.29%-697.56%-1,161.15%-41.76%21.47%-190.29%-113.41%53.49%-80.42%
EBIT Margin 736.77%-116.85%-290.43%-709.06%-1,195.63%-49.51%16.00%-196.76%-124.27%48.80%-104.11%
EBITDA Margin 836.77%-172.63%-281.25%-699.88%-1,158.34%-41.74%21.45%-190.30%-113.65%53.00%-81.70%
Operating Margin 736.77%-116.85%-290.43%-709.06%-1,195.63%-49.51%16.00%-196.76%-124.27%48.80%-104.11%
Net Margin 906.82%-220.90%-282.65%-697.56%-1,158.79%-41.76%21.47%-190.29%-113.45%52.93%-81.25%
FCF Margin 764.41%232.31%-334.11%-644.65%-265.02%39.23%-63.59%-147.36%-36.67%29.86%-23.54%
Efficiency
Assets Average 209.51M187.02M180.75M265.89M308.17M227.72M176.61M255.32M372.17M
Equity Average 152.50M134.99M90.25M72.98M126.92M124.69M77.04M147.67M268.04M
Invested Capital 169.07M135.92M134.05M46.45M99.51M154.32M95.06M59.02M236.32M299.76M
Asset Utilization Ratio 0.070.050.040.390.560.160.230.980.21
Leverage & Solvency
Interest Coverage Ratio -7.37-2.08
Equity Ratio 0.740.720.730.260.280.590.490.370.670.76
Times Interest Earned -7.37-2.08
Valuation
Enterprise Value 391.47M166.00M278.31M150.23M235.64M86.74M-29.67M116.66M140.45M43.04M
Market Capitalization 585.81M340.41M447.36M306.03M517.17M267.88M102.86M235.50M371.32M309.73M
Return Ratios
Return on Sales 8.37%-1.71%-2.83%-6.98%-11.59%-0.42%0.21%-1.90%-1.13%0.53%-0.81%
Return on Capital Employed -0.21%-0.42%-0.61%-0.27%0.10%-0.42%-0.49%0.64%-0.26%
Return on Invested Capital -1.01%0.82%
Return on Assets -0.19%-0.38%-0.49%-0.16%0.12%-0.31%-0.26%0.52%-0.17%
Return on Equity -0.26%-0.52%-0.98%-0.60%0.29%-0.57%-0.60%0.90%-0.24%